Precipio Signs First IV-Cell Customer Agreement
10 mai 2022 10h30 HE
|
Precipio, Inc.
NEW HAVEN, Conn., May 10, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that American Oncology Network (AON) of Fort Myers, Florida,...
Insights on the Lab-on-a-Chip Global Market to 2027 - by Product Type, Application, Technology, End-user and Region
03 févr. 2022 06h18 HE
|
Research and Markets
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Global Lab-on-a-Chip Market 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global lab-on-a-chip market is anticipated to...
Global Cytogenetics Markets, Technology, & Competitive Landscape Report 2021-2025 & 2030
18 nov. 2021 07h18 HE
|
Research and Markets
Dublin, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The "Cytogenetics - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
Global Molecular Cytogenetics Markets 2021-2027: Challenges and Opportunities for Clinical Diagnostics amid the Pandemic
28 juin 2021 07h08 HE
|
Research and Markets
Dublin, June 28, 2021 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Molecular...
Global Cytogenetics Market (2020 to 2030) - Key Technologies, Markets & Companies
23 avr. 2021 05h58 HE
|
Research and Markets
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Cytogenetics - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
Global Molecular Cytogenetics Markets, 2020-2027: Critical Importance of Molecular Biology in Laboratory Processes - Cornerstone for Present & Future Growth
02 déc. 2020 08h28 HE
|
Research and Markets
Dublin, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19...
Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™
06 oct. 2020 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase...
Cytogenetics Market, 2029
10 sept. 2020 10h24 HE
|
Research and Markets
Dublin, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The "Cytogenetics - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...
Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell™
20 août 2020 13h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement with ADS...
Clinical Validations for IV-Cell™ and HemeScreen™ Completed
26 sept. 2019 10h53 HE
|
Precipio, Inc.
Orders expected from several major labs both domestically and internationally NEW HAVEN, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO),...